Patients with immunodeficiency are at a higher risk for severe outcomes from SARS-CoV-2 compared to healthy individuals.
A study evaluated immune responses in various immunocompromised patients, showing they had significantly lower T-cell and B-cell responses to the virus compared to healthy controls.
The findings highlight the importance of additional precautions for immunocompromised patients to protect them from COVID-19 due to their reduced immune function.